Equities Analysts Offer Predictions for IRWD Q3 Earnings
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Investment analysts at Zacks Research decreased their Q3 2026 earnings per share (EPS) estimates for shares of Ironwood Pharmaceuticals in a report issued on Wednesday, March 26th. Zacks Research analyst R. Department now expects that the biotechnology company will post earnings per share of $0.07 for the […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Investment analysts at Zacks Research decreased their Q3 2026 earnings per share (EPS) estimates for shares of Ironwood Pharmaceuticals in a report issued on Wednesday, March 26th. Zacks Research analyst R. Department now expects that the biotechnology company will post earnings per share of $0.07 for the […]
